600 MBq/mL solution for injection

DRUG2 trials

Sponsors

Universitaetsklinikum Aachen AöR, Oslo University Hospital HF

Conditions

Patients with newly diagnosed cerebral gliomasmultiple myelomarecurrent cerebral gliomas and brain metastases.

Phase 2

Comparison of 18F-Fluciclovine PET versus 18F-Fluoroethyltyrosine PET in patients with newly diagnosed cerebral gliomas, recurrent cerebral gliomas and brain metastases – an open label single centre single arm prospective basket trial

Active, not recruitingCTIS2023-507786-26-00

Universitaetsklinikum Aachen AöRPatients with newly diagnosed cerebral gliomas, recurrent cerebral gliomas and brain metastases.

Start: 2024-08-14Target: 80Updated: 2025-08-26

Imaging multiple myeloma patients in the REMNANT study with Fluciclovine PET/CT (FLUCIPET)

RecruitingCTIS2024-517095-38-00

Oslo University Hospital HFmultiple myeloma

Start: 2023-12-18Target: 50Updated: 2025-05-27